Assessment of the response in vivo and in vitro of Plasmodium falciparum to sulphadoxine-pyrimethamine in the malarious areas of Iran

Studies of drug resistance of Plasmodium falciparum cases from SE Iran were carried out in vivo and in vitro during 1990-91. In a study of 26 chloroquine-resistant infections, using amodiaquine (25 mg kg-1 over 3 days), followed by two-thirds of the standard dose of sulphadoxine-pyrimethamine, six cases were resistant at the RI(3) and RII(3) levels. An additional study testing the standard dose of sulphadoxine-pyrimethamine in 43 chloroquine-resistant cases revealed five (11.6%) resistant at the RI(2) and RII(3) levels. Six of the above resistant infections were contracted in Hormozgan, three in Sistan-Baluchestan, one in Kerman provinces of Iran and one in Pakistan. In five of 22 successful in-vitro tests, carried out on different isolates, the parasites grew to schizonts (> or = 8 nuclei) in the wells containing 1000 pmol sulphadoxine and 12.5 pmol pyrimethamine, indicative of resistance.

Medienart:

Artikel

Erscheinungsjahr:

1993

Erschienen:

1993

Enthalten in:

Zur Gesamtaufnahme - volume:96

Enthalten in:

The Journal of tropical medicine and hygiene - 96(1993), 4 vom: 20. Aug., Seite 237-40

Sprache:

Englisch

Beteiligte Personen:

Edrissian, G H [VerfasserIn]
Afshar, A [VerfasserIn]
Sayedzadeh, A [VerfasserIn]
Mohsseni, G [VerfasserIn]
Satvat, M T [VerfasserIn]

Themen:

220236ED28
88463U4SM5
886U3H6UFF
A7V27PHC7A
Amodiaquine
Chloroquine
Drug Combinations
Journal Article
Pyrimethamine
Quinine
Research Support, Non-U.S. Gov't
Sulfadoxine
Z3614QOX8W

Anmerkungen:

Date Completed 09.09.1993

Date Revised 18.03.2022

published: Print

Citation Status MEDLINE

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM083202889